Back

Prevalence and incidence of diastolic dysfunction in new-onset atrial fibrillation: implications for clinical and preclinical HFpEF

28 August 2023 (12:15 - 13:00)
Organised by: Logo
Congress Presentation Part of: Comorbidities in heart failure: bench to bedside Clinical ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Assistant Professor Jwan Naser

Mayo Clinic, Rochester (United States of America)

4 More presentations in this session

Presentation thumbnail
Soluble transferrin receptor as a marker of tissue iron deficiency: impact on cardiac, systemic, hematinic and neurohormonal biomarkers in patients with heart failure without systemic iron deficiency
Doctor L. Alcoberro (Hospitalet De Llobregat, ES)
Abstract Slides Video
Presentation thumbnail
Impact of worsening renal function in patients with incident heart failure across the spectrum of ejection fraction: a population-based longitudinal study
Doctor H. Wang (Dundee, GB)
Abstract Slides Video
Presentation thumbnail
Impact of Clostridioides difficile infection in heart failure hospitalizations: analysis from the national inpatient sample database
Doctor I. Badu (Chicago, US)
Abstract Slides Video
Presentation thumbnail
Low muscle strength as a predictor of incident pneumonia in older patients with heart failure: sub-analysis of fragile-hf
Doctor K. Yamaguchi (Suita, JP)
Abstract Slides Video

Access the full session

Session thumbnail
Comorbidities in heart failure: bench to bedside

The Event

Event poster

ESC Congress 2023

28 August 2023 12:15 CET
You may be interested in
thumbnail
Congress Presentation
Atrial fibrillation and HFpEF: diagnosis and prognosis
thumbnail
Congress Presentation
Prevalence of diastolic disfunction in atrial fibrillation and its impact on quality of life
thumbnail
Congress Session
Atrial fibrillation miscellaneous

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources